The released batch was manufactured at Everest's Jiashan manufacturing site using the Company's proprietary mRNA platform, in compliance with global GMP standards. EVM14 is an off-the-shelf ...

A study in Chemistry A European Journal reveals that reduced MUC1 antigen density on gold nanoparticles still elicits potent ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing ...

While research in mice has shown encouraging results, the next phases of human trials will need to confirm safety and ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from ...

For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

GEO-CM04S1 Demonstrates Superior T Cell Responses Compared to mRNA Vaccine in Phase 2 Trial Among Immunocompromised Patients ...

Dubai, United Arab Emirates; June, 2025 - Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic ...

A vaccine that could help fight one of the deadliest forms of cancer is in the works - and could one day become a reality.

This burgeoning market reflects advancements in precision oncology, leveraging neoantigen vaccines tailored to ...